What Big Development Is Canopy Growth (TSX:WEED) Expecting in the Next 24 Months?

Canopy Growth Corp (TSX:WEED)(NYSE:CGC) Co-CEO Bruce Linton is getting ready for the next big wave to hit the cannabis industry.

| More on:
edit Jars of marijuana

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

Things have been moving fast in the cannabis industry over the past few years. Not only has Canada legalized marijuana, but many U.S. states have as well, with Illinois poised to become the 11th state. The passing of the farm bill late last year opened CBD derived from hemp as an option for companies as well.

The one wrinkle there is that as CBD has not yet been permitted by the Food and Drug Administration (FDA), it’s still technically not permitted within food and beverages in the U.S. The FDA has recently begun hearings on CBD, and while there could be progress on the issue, it’s still likely a long way away from being permitted. Federally, marijuana also remains illegal with no end in sight.

And so as much progress as there has been on cannabis, there are still some big hurdles left. However, one company that is bullish on where the industry is headed is Canopy Growth Corp (TSX:WEED)(NYSE:CGC). In a recent interview, Co-CEO Bruce Linton said his company believes there will be a significant development in the industry within the next 18-24 months.

What could he be alluding to?

While it would be significant, I don’t think he’s talking about the FDA approving CBD. Although it would be a big step for the industry and open up a lot of growth, it’s not really an obstacle today. There’s no shortage of cannabis-infused foods and beverages in the U.S. that have been able to continue to sell their products without a federal agency coming down hard on them for doing so.

Rather, I believe that Linton is referring to the federal legalization of cannabis across the U.S. In about 18 months, we’ll know who the next U.S. president will be, which could be a big turning point for the industry. If a democratic leadership takes control of the White House, it could lead to the legalization of marijuana in very short order, especially as it could be used as a platform to help win votes.

By and large, Democratic candidates have been in favour of legalizing marijuana, and the next federal election could prove to be a big turning point for the industry. With the republicans still in power, however, it’s unlikely that we’ll see anything on that front anytime soon. Linton and Canopy Growth made a big bet with their deal with Acreage Holdings recently, and they wouldn’t have done so blindly without believing that something could be in the works soon.

Former republican speaker John Boehner is, after all, on Acreage’s team and would be well connected to Washington — and thus know how strong the possibility of legalization is. If there’s one thing we’ve come to learn about Linton, it’s that he doesn’t show all his cards and he wouldn’t make a deal with Acreage without having high expectations of something happening to confirm the deal very soon.

If within 24 months we do see legalization take place in the U.S., then that will change the industry in a flash. It’ll open the doors for other industries to enter the mix without fear of legal repercussions. We’ll be off to the races, and Canopy Growth and Acreage will have a significant head start over the competition.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor David Jagielski has no position in any of the stocks mentioned.

More on Cannabis Stocks

Cannabis smoke
Cannabis Stocks

Canopy Growth Stock: Is Now a Good Time to Invest?

The road ahead is highly uncertain for Canopy Growth, as the stock is plagued with losses and seemingly unsurmountable industry…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

TLRY Stock: Should You Invest Now?

TLRY is a Canadian cannabis stock which is trading 91% below record highs. Let's see if you should own TLRY…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Is Tilray Stock a Buy in February 2023?

Despite the volatile cannabis sector, Tilray could be a superb buy for long-term investors.

Read more »

Young woman sat at laptop by a window
Cannabis Stocks

Is SNDL Stock a Buy in February 2023?

SNDL is a beaten-down cannabis stock. While its revenue growth is exceptional, a weak balance sheet has driven stock prices…

Read more »

A cannabis plant grows.
Cannabis Stocks

TLRY Stock: Here’s What’s Coming in 2023

Tilray Inc. (TSX:TLRY) is geared up for big growth this decade and looks like one of the top cannabis stocks…

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

Canopy Growth Stock: Here’s What’s Coming in 2023

Canopy Growth stock has made a lot of new moves in the last few months, but where is the company…

Read more »

A cannabis plant grows.
Cannabis Stocks

Better Cannabis Buy: Canopy Growth Stock or Tilray?

Only two TSX weed stocks can deliver substantial returns in the highly anticipated growth of the global cannabis market.

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Is Tilray Stock a Buy in January 2023?

Tilray stock has lost 50% of its value in the last 12 months, in line with its peers.

Read more »